Morgan Stanley analyst Joseph Moore raised the firm’s price target on Astera Labs (ALAB) to $125 from $99 and keeps an Overweight rating on the shares. The firm, which thinks that the increase in enthusiasm for AI semis is “justified by long term strength in the business,” raised targets across the board among its AI-linked semiconductors coverage.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB:
- Astera Labs, Inc.: Strong Market Positioning and Growth Potential Amid AI Infrastructure Expansion
- Astera Labs, Inc.: Buy Rating Affirmed Amid Promising Growth Prospects and Earnings Upside
- Astera Labs price target raised to $130 from $95 at Jefferies
- Astera Labs downgraded to Market Perform at Northland on valuation
- Astera Labs downgraded to Market Perform from Outperform at Northland